• Trials Underway to Study COVID-19 Impact on Dialysis Patients americanpharmaceuticalreview
    August 24, 2020
    DaVita Clinical Research (DCR), a subsidiary of DaVita Inc., has begun enrollment on two clinical research trials to study how COVID-19 affects people with end stage kidney disease (ESKD) who are currently receiving dialysis.
PharmaSources Customer Service